REVANCE THERAPEUTICS INC's ticker is RVNC and the CUSIP is 761330109. A total of 159 filers reported holding REVANCE THERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is 2.29 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $9,612 | -72.7% | 838 | -39.8% | 0.00% | -100.0% |
Q2 2023 | $35,257 | -21.4% | 1,393 | 0.0% | 0.00% | 0.0% |
Q1 2023 | $44,869 | +1458.0% | 1,393 | +792.9% | 0.00% | – |
Q4 2022 | $2,880 | -58.9% | 156 | -36.8% | 0.00% | – |
Q3 2022 | $7,000 | +250.0% | 247 | +126.6% | 0.00% | – |
Q2 2022 | $2,000 | 0.0% | 109 | +28.2% | 0.00% | – |
Q1 2022 | $2,000 | -66.7% | 85 | -76.4% | 0.00% | – |
Q4 2021 | $6,000 | +200.0% | 360 | +445.5% | 0.00% | – |
Q3 2021 | $2,000 | 0.0% | 66 | -18.5% | 0.00% | – |
Q2 2021 | $2,000 | 0.0% | 81 | +22.7% | 0.00% | – |
Q1 2021 | $2,000 | 0.0% | 66 | 0.0% | 0.00% | – |
Q4 2020 | $2,000 | 0.0% | 66 | 0.0% | 0.00% | – |
Q3 2020 | $2,000 | 0.0% | 66 | 0.0% | 0.00% | – |
Q2 2020 | $2,000 | +100.0% | 66 | 0.0% | 0.00% | – |
Q1 2020 | $1,000 | 0.0% | 66 | 0.0% | 0.00% | – |
Q4 2019 | $1,000 | 0.0% | 66 | 0.0% | 0.00% | – |
Q3 2019 | $1,000 | 0.0% | 66 | 0.0% | 0.00% | – |
Q2 2019 | $1,000 | – | 66 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Essex Woodlands Management, Inc. | 3,342,047 | $52,671,000 | 26.22% |
NovaQuest Capital Management, L.L.C. | 1,558,426 | $24,561,000 | 22.85% |
Sio Capital Management, LLC | 254,581 | $4,012,000 | 1.08% |
ArrowMark Colorado Holdings LLC | 3,409,217 | $53,729,000 | 0.51% |
Fosun International Ltd | 472,532 | $7,447,000 | 0.47% |
Rhenman & Partners Asset Management AB | 193,181 | $3,045,000 | 0.36% |
Phoenix Investment Adviser LLC | 4,900 | $77,000 | 0.17% |
HARBOURVEST PARTNERS LLC | 26,565 | $419,000 | 0.15% |
Quinn Opportunity Partners LLC | 56,672 | $893,000 | 0.12% |
MFN Partners Management, LP | 46,000 | $725,000 | 0.12% |